Krilogy Financial LLC Moderna, Inc. Transaction History

Krilogy Financial LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$135.66 - $197.02 $22,383 - $32,508	-165 Reduced 8.99%	1,671 $256,000
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $236 - $420	-2 Reduced 0.11%	1,836 $329,000
Q3 2022 Oct 06, 2022	SELL	$118.07 - $194.18 $5,549 - $9,126	-47 Reduced 2.49%	1,838 $217,000
Q2 2022 Jul 14, 2022	SELL	$117.13 - $176.59 $16,046 - $24,192	-137 Reduced 6.78%	1,885 $269,000
Q1 2022 Apr 28, 2022	SELL	$126.46 - $235.05 $182,102 - $338,472	-1,440 Reduced 41.59%	2,022 $348,000
Q4 2021 Jan 27, 2022	SELL	$225.82 - $368.51 $35,905 - $58,593	-159 Reduced 4.39%	3,462 $879,000
Q3 2021 Oct 25, 2021	BUY	$221.9 - $484.47 $59,469 - $129,837	268 Added 7.99%	3,621 $1.39 Million
Q2 2021 Jul 20, 2021	SELL	$129.91 - $234.98 $44,559 - $80,598	-343 Reduced 9.28%	3,353 $788,000
Q1 2021 Apr 21, 2021	SELL	$109.18 - $185.98 $3,384 - $5,765	-31 Reduced 0.83%	3,696 $484,000
Q4 2020 Feb 11, 2021	BUY	$65.74 - $169.86 $25,112 - $64,886	382 Added 11.42%	3,727 $389,000
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $181,767 - $317,273	3,345 New	3,345 $237,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.